GuidanceMHRA
Supply unlicensed medicinal products (specials)
Guidance on manufacturing, importing, distributing and supplying specially manufactured or ordered products, including cannabis-based products for medicinal use in humans (CBPMs), known as 'specials'
First published: May 5, 2014Last updated: Jan 29, 2025Changes: 4
Latest change: A new Guidance document, complementary to MHRA Guidance note 14, has been included linking different government pages of interest to the supply unlicensed medicinal products in the UK.
The full document, source attachments, and change history are available on KeyPedia. Sign in to view.